Literature DB >> 18476153

Chlorhexidine vs. Sterile vaginal wash during labor to prevent neonatal infection.

N L Eriksen1, K M Sweeten, J D Blanco.   

Abstract

OBJECTIVE: The purpose of this study was to determine if a dilute solution of chlorhexidine used as a one-time vaginal wash intrapartum can reduce the use of postnatal antibiotics and neonatal infection.
METHODS: Term pregnant women in labor were prospectively randomized to receive either 20 cc of 0.4% chlorhexidine (n = 481) or 20 cc of sterile water (n = 466) placebo. Exclusion criteria included fetal distress, clinical infection, cervical dilatation >6 cm, and known allergy to chlorhexidine. Outcome variables included the incidence of neonatal pneumonia, culture proven neonatal sepsis, and use of the antibiotics in the neonate. Continuous variables were compared using the Mann-Whitney U-test and discrete variables were compared with the chi-square test.
RESULTS: The length of ruptured membranes (mean +/- S.D.) between the chlorhexidine group (408 +/- 589 min) and control group (352 +/- 318 min) was not significantly different (P = 0.85, 95% confidence interval 354-462). Fifteen neonates (3.2%) in the chlorhexidine group and 9 (1.9%) in the control group received antibiotics in the postnatal period (P = 0.32, 95% confidence interval 0.72-3.72). There was one case of pneumonia in the control group and no cases of sepsis in either group.
CONCLUSIONS: A one-time chlorhexidine vaginal wash does not decrease the use of antibiotics or incidence of neonatal infection in our population.

Entities:  

Year:  1997        PMID: 18476153      PMCID: PMC2364551          DOI: 10.1155/S1064744997000495

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN: 1064-7449


  12 in total

1.  Prevention of group B streptococci transmission during delivery by vaginal application of chlorhexidine gel.

Authors:  L A Kollée; I Speyer; M A van Kuijck; R Koopman; J M Dony; J H Bakker; R G Wintermans
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1989-04       Impact factor: 2.435

2.  Prevention of neonatal infections by vaginal chlorhexidine disinfection during labour.

Authors:  T Henrichsen; R Lindemann; L Svenningsen; K Hjelle
Journal:  Acta Paediatr       Date:  1994-09       Impact factor: 2.299

3.  The effects of daily bathing of neonatal rhesus monkeys with an antimicrobial skin cleanser containing chlorhexidine gluconate.

Authors:  L E Gongwer; K Hubben; R S Lenkiewicz; E R Hart; B Y Cockrell
Journal:  Toxicol Appl Pharmacol       Date:  1980-02       Impact factor: 4.219

4.  Chlorhexidine versus sterile water vaginal wash during labor to prevent peripartum infection.

Authors:  K M Sweeten; N L Eriksen; J D Blanco
Journal:  Am J Obstet Gynecol       Date:  1997-02       Impact factor: 8.661

5.  Chlorhexidine for prevention of neonatal colonization with group B streptococci. III. Effect of vaginal washing with chlorhexidine before rupture of the membranes.

Authors:  K K Christensen; P Christensen; A K Dykes; G Kahlmeter
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1985-04       Impact factor: 2.435

6.  Term maternal and neonatal complications of acute chorioamnionitis.

Authors:  J C Hauth; L C Gilstrap; G D Hankins; K D Connor
Journal:  Obstet Gynecol       Date:  1985-07       Impact factor: 7.661

7.  Prevention of excess neonatal morbidity associated with group B streptococci by vaginal chlorhexidine disinfection during labour. The Swedish Chlorhexidine Study Group.

Authors:  L G Burman; P Christensen; K Christensen; B Fryklund; A M Helgesson; N W Svenningsen; K Tullus
Journal:  Lancet       Date:  1992-07-11       Impact factor: 79.321

8.  Antimicrobial effect of chlorhexidine and povidone-iodine on vaginal bacteria.

Authors:  H Vorherr; U F Vorherr; P Mehta; J A Ulrich; R H Messer
Journal:  J Infect       Date:  1984-05       Impact factor: 6.072

9.  Chlorhexidine for prevention of neonatal colonization with group B streptococci. I. In vitro effect of chlorhexidine on group B streptococci.

Authors:  K K Christensen; P Christensen; A K Dykes; G Kahlmeter; D N Kurl; V Lindén
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1983-11       Impact factor: 2.435

10.  Chlorhexidine for prevention of neonatal colonization with group B streptococci. II. Chlorhexidine concentrations and recovery of group B streptococci following vaginal washing in pregnant women.

Authors:  A K Dykes; K K Christensen; P Christensen; G Kahlmeter
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1983-11       Impact factor: 2.435

View more
  4 in total

Review 1.  Safety and impact of chlorhexidine antisepsis interventions for improving neonatal health in developing countries.

Authors:  Luke C Mullany; Gary L Darmstadt; James M Tielsch
Journal:  Pediatr Infect Dis J       Date:  2006-08       Impact factor: 2.129

2.  Neonatal sepsis definitions from randomised clinical trials.

Authors:  Rían Hayes; Jack Hartnett; Gergana Semova; Cian Murray; Katherine Murphy; Leah Carroll; Helena Plapp; Louise Hession; Jonathan O'Toole; Danielle McCollum; Edna Roche; Elinor Jenkins; David Mockler; Tim Hurley; Matthew McGovern; John Allen; Judith Meehan; Frans B Plötz; Tobias Strunk; Willem P de Boode; Richard Polin; James L Wynn; Marina Degtyareva; Helmut Küster; Jan Janota; Eric Giannoni; Luregn J Schlapbach; Fleur M Keij; Irwin K M Reiss; Joseph Bliss; Joyce M Koenig; Mark A Turner; Christopher Gale; Eleanor J Molloy
Journal:  Pediatr Res       Date:  2021-11-06       Impact factor: 3.756

Review 3.  Vaginal chlorhexidine during labour for preventing maternal and neonatal infections (excluding Group B Streptococcal and HIV).

Authors:  Pisake Lumbiganon; Jadsada Thinkhamrop; Bandit Thinkhamrop; Jorge E Tolosa
Journal:  Cochrane Database Syst Rev       Date:  2014-09-14

4.  What is the result of vaginal cleansing with chlorhexidine during labour on maternal and neonatal infections? A systematic review of randomised trials with meta-analysis.

Authors:  Charlotte Bell; Laura Hughes; Trevor Akister; Vin Ramkhelawon; Amie Wilson; David Lissauer
Journal:  BMC Pregnancy Childbirth       Date:  2018-05-08       Impact factor: 3.007

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.